Axplora

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    NICE approval is not enough: why the UK’s next medicines challenge is operational delivery A medicine is not truly accessible until it can be manufactured, procured, stocked, prescribed, dispensed and delivered reliably. That distinction is becoming increasingly...
  2. Strengthening US pharmaceutical supply: SCHOTT Pharma inaugurates expanded vial production in Lebanon, PA SCHOTT Pharma has inaugurated new production lines for both standard and sterile ready-to-use (RTU) glass vials designed to store a wide range of drugs — from biologics and...
  3. Stipple Bio enters into multi-target license agreement with Lonza to advance precision oncology ADC therapies Stipple Bio’s Pointillist Platform identifies tumour-specific cell surface epitopes that, when combined with Lonza’s clinically validated ADC platform, may enable...
  4. Ardena appoints Ariane de Ganck as Chief Scientific Officer Ardena, a specialist pharmaceutical CDMO and bioanalytical CRO enabling precision medicines and complex therapies, today announced the appointment of Ariane de Ganck, PhD, as...
  5. Compact, economical and sustainable cooling solutions for laboratories Huber Unichillers offer space-saving and environmentally friendly temperature control for research and industrial applications

Upcoming event

BIO International Convention

22–25 June 2026 | Convention | Boston, US See all

Related Content

You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Purification: a critical success factor in peptide programmes

This article examines why advanced chromatography, process intensification and sustainability initiatives can help manufacturers to improve process efficiency and long-term supply security
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Axplora invests in Le Mans lyophilisation expansion and appoints new site head

Axplora has revealed plans to expand lyophilisation capacity at its Le Mans ADC manufacturing site, with CEO Martin Meeson speaking exclusively to Manufacturing Chemist about tightening European capacity and how the investment aims to prevent manufacturing becoming a bottleneck for programmes
Finance

Axplora announces €100m global investment drive to expand API and ADC manufacturing capacity

Axplora is investing more than €100m across its global network in 2025, with major projects in France, Italy and India aimed at strengthening small molecule API production and expanding antibody-drug conjugate capabilities to support future growth
Manufacturing

Axplora announces €35m expansion at Farmabios to double footprint and fuel long-term growth

This latest investment builds on the €45m already committed during the past 5 years, bringing Axplora’s total recent investment in Farmabios to more than €80 million
Manufacturing

Axplora's Chasse-sur-Rhône CDMO site passes ninth inspection in a row

The API small molecule manufacturing site has been deemed cGMP compliant by the French medicines regulatory authority
You need to be a subscriber to read this article.
Click here to find out more.
Distribution

DCAT preview: the future of pharma manufacturing

Ahead of the upcoming trade show, Dr Kevin Robinson caught up with pharmaceutical industry experts to discuss how they’re innovating for resilience and sustainability in 2025 and beyond
Manufacturing

Axplora expands ADC payload manufacturing capacity at Le Mans site

The CDMO will now be able to produce cytotoxic payload batches of up to 1.5kg, allowing it to better serve its larger clients in the biopharmaceutical space
Subscribe now